Observational studyDrug design, development and therapy2026

An Immune Model Incorporating NK Cells and IL-12 to Predict the Efficacy of the Initial Treatment Cycle of Efgartigimod in Generalized Myasthenia Gravis.

Hanyu Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.